SEI Investments’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
WBG
PVH
TSS
SEI Investments's XPH Position: Q1 2017 in Review
SEI Investments sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2017, closing a stake of 194 shares — an estimated $8K sold.
SEI Investments first reported a position in XPH in Q1 2016 and held it in 4 quarters. The position peaked at $20K in Q3 2016. 79 funds tracked by Wall St. Rank hold XPH as of Q1 2017.
- SEI Investments reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
- SEI Investments sold 194 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2017, an estimated $8K.
- SEI Investments first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2016 and held it in 4 quarters.
- SEI Investments's State Street SPDR S&P Pharmaceuticals ETF position peaked at $20K in Q3 2016.
- 79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2017.
Based on SEI Investments's 13F filing for Q1 2017, filed 5 May 2017.